Amcor announced an investment to establish new thermoforming capabilities for medical packaging in its Sligo, Ireland, healthcare packaging facility. The multi-million-dollar investment will strengthen Amcor’s leadership in the growing industry for sterile packaging, offering customers in Europe and North America another site with comprehensive healthcare solutions.
The additional capabilities in our Sligo site allow us to provide customers with even more differentiated and efficient solutions to meet their healthcare packaging needs. With our global scale and innovation capabilities, Amcor is uniquely positioned to capture growing demand for both medical and pharmaceutical packaging products globally.Peter Konieczny, Chief Commercial Officer of Amcor
Through this investment, the Sligo site will feature Class 7 cleanroom manufacturing environments and state-of-the-art thermoforming operations, fully certified to ISO 13485 standards and meeting the highest regulatory requirements. Amcor will also create a full design studio to support product development, enabling customers to tap into local and global expertise and resources across the company’s growing network of global innovation centers.
According to Market Data Forecast, the European medical device segment, which relies on this type of packaging, is expected to grow at an annual rate of more than 4%, reaching $171 billion by 2027. With this investment in Ireland and the new facility in Singapore that came online at the end of 2021, Amcor is actively meeting the growing global demands of customers in the medical and pharmaceutical industries.